Parma, Italy

Elisa Monari

This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 6 EPO patents. Top assignee: Chiesi Farmaceutici S.p.a.. Active years: 2014-2021.


% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2014-2021

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Elisa Monari: Innovator in Pharmaceutical Formulations

Introduction

Elisa Monari is a prominent inventor based in Parma, Italy. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of dry powder formulations for respiratory diseases. With a total of 3 patents to her name, her work has the potential to improve treatment options for patients suffering from inflammatory or obstructive airway diseases.

Latest Patents

Elisa's latest patents include innovative formulations that combine corticosteroids and beta-adrenergic drugs for administration by inhalation. One of her notable inventions is a dry powder formulation that effectively treats inflammatory or obstructive airway diseases. Another patent focuses on the process of preparing this dry powder formulation, highlighting its therapeutic uses and benefits for patients.

Career Highlights

Elisa Monari is currently associated with Chiesi Farmaceutici S.p.a., a company known for its commitment to developing innovative pharmaceutical solutions. Her work at Chiesi has allowed her to explore new avenues in drug formulation, contributing to advancements in respiratory therapies.

Collaborations

Elisa has collaborated with esteemed colleagues such as Anna Maria Cantarelli and Daniela Cocconi. These partnerships have fostered a collaborative environment that enhances the research and development of effective pharmaceutical products.

Conclusion

Elisa Monari's contributions to the field of pharmaceutical formulations are noteworthy. Her innovative patents and collaborations reflect her dedication to improving healthcare solutions for respiratory diseases. Through her work, she continues to make a significant impact in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…